FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4295997730> ?p ?o ?g. }

• W4295997730 endingPage "3370" @default.
• W4295997730 startingPage "3359" @default.
• W4295997730 abstract "Tuberculosis (TB) remains one of the most serious diseases caused by a single organism. Multiple (MDR) and extensively (XDR) drug resistant disease poses a threat to global health and requires new drugs and/or innovative approaches to treatment. A number of drugs have been proposed as inhaled therapy for TB, frequently prepared by spray drying. CPZEN-45 is a novel anti-tubercular drug that has poor oral bioavailability but has shown promise when administered via inhalation. Excipient-free CPZEN-45 HCl has been spray dried into a powder with physicochemical characteristics, aerodynamic particle size distribution, and delivered dose suitable for consideration as an inhaled product. The mass median aerodynamic diameter (MMAD) and geometric standard deviation (GSD) of the powder delivered using a RS01 inhaler were 2.62 ± 0.04 μm and 1.76 ± 0.09, respectively. Additionally, the powder was physically and chemically stable after storage at ambient conditions for >1.5 years with particle size similar to freshly manufactured product. Overages in spray dried powder were recycled the powder and resprayed into drug product likewise resulting in negligible change in quality thus allowing for further preclinical characterization as necessary. CPZEN-45 was scaled up using pilot-scale manufacturing equipment where the density of the powder was increased to facilitate larger delivered doses without affecting the aerodynamic performance properties. The spray dried powders were suitable for pharmacokinetics, efficacy and preclinical toxicology studies. The final method of manufacture may be used directly for CGMP particle manufacture to support IND and Phase I clinical trials and beyond." @default.
• W4295997730 created "2022-09-16" @default.
• W4295997730 creator A5007758463 @default.
• W4295997730 creator A5011461309 @default.
• W4295997730 creator A5015092281 @default.
• W4295997730 creator A5017911908 @default.
• W4295997730 creator A5023723216 @default.
• W4295997730 creator A5031455312 @default.
• W4295997730 creator A5034750758 @default.
• W4295997730 creator A5046013845 @default.
• W4295997730 creator A5060702845 @default.
• W4295997730 creator A5066929584 @default.
• W4295997730 creator A5071846305 @default.
• W4295997730 creator A5074573828 @default.
• W4295997730 creator A5089061641 @default.
• W4295997730 date "2022-09-16" @default.
• W4295997730 modified "2023-10-15" @default.
• W4295997730 title "Optimization and Scale Up of Spray Dried CPZEN-45 Aerosol Powders for Inhaled Tuberculosis Treatment" @default.
• W4295997730 cites W1519480055 @default.
• W4295997730 cites W1575908580 @default.
• W4295997730 cites W1869177231 @default.
• W4295997730 cites W1980803266 @default.
• W4295997730 cites W2016565975 @default.
• W4295997730 cites W2018348121 @default.
• W4295997730 cites W2036270401 @default.
• W4295997730 cites W2041448568 @default.
• W4295997730 cites W2043598462 @default.
• W4295997730 cites W2058889783 @default.
• W4295997730 cites W2112135623 @default.
• W4295997730 cites W2127971692 @default.
• W4295997730 cites W2947365237 @default.
• W4295997730 cites W2963914914 @default.
• W4295997730 cites W2970292895 @default.
• W4295997730 cites W3009599329 @default.
• W4295997730 cites W3172725443 @default.
• W4295997730 cites W3198937258 @default.
• W4295997730 doi "https://doi.org/10.1007/s11095-022-03393-w" @default.
• W4295997730 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36114362" @default.
• W4295997730 hasPublicationYear "2022" @default.
• W4295997730 type Work @default.
• W4295997730 citedByCount "1" @default.
• W4295997730 countsByYear W42959977302023 @default.
• W4295997730 crossrefType "journal-article" @default.
• W4295997730 hasAuthorship W4295997730A5007758463 @default.
• W4295997730 hasAuthorship W4295997730A5011461309 @default.
• W4295997730 hasAuthorship W4295997730A5015092281 @default.
• W4295997730 hasAuthorship W4295997730A5017911908 @default.
• W4295997730 hasAuthorship W4295997730A5023723216 @default.
• W4295997730 hasAuthorship W4295997730A5031455312 @default.
• W4295997730 hasAuthorship W4295997730A5034750758 @default.
• W4295997730 hasAuthorship W4295997730A5046013845 @default.
• W4295997730 hasAuthorship W4295997730A5060702845 @default.
• W4295997730 hasAuthorship W4295997730A5066929584 @default.
• W4295997730 hasAuthorship W4295997730A5071846305 @default.
• W4295997730 hasAuthorship W4295997730A5074573828 @default.
• W4295997730 hasAuthorship W4295997730A5089061641 @default.
• W4295997730 hasBestOaLocation W42959977301 @default.
• W4295997730 hasConcept C108294719 @default.
• W4295997730 hasConcept C112705442 @default.
• W4295997730 hasConcept C126322002 @default.
• W4295997730 hasConcept C147789679 @default.
• W4295997730 hasConcept C178790620 @default.
• W4295997730 hasConcept C181389837 @default.
• W4295997730 hasConcept C185592680 @default.
• W4295997730 hasConcept C187530423 @default.
• W4295997730 hasConcept C192562407 @default.
• W4295997730 hasConcept C2776042228 @default.
• W4295997730 hasConcept C2776954882 @default.
• W4295997730 hasConcept C2777239854 @default.
• W4295997730 hasConcept C2777419714 @default.
• W4295997730 hasConcept C2779345167 @default.
• W4295997730 hasConcept C2779587474 @default.
• W4295997730 hasConcept C2780035454 @default.
• W4295997730 hasConcept C2780261241 @default.
• W4295997730 hasConcept C2994497548 @default.
• W4295997730 hasConcept C42219234 @default.
• W4295997730 hasConcept C43617362 @default.
• W4295997730 hasConcept C45904493 @default.
• W4295997730 hasConcept C71924100 @default.
• W4295997730 hasConcept C98274493 @default.
• W4295997730 hasConceptScore W4295997730C108294719 @default.
• W4295997730 hasConceptScore W4295997730C112705442 @default.
• W4295997730 hasConceptScore W4295997730C126322002 @default.
• W4295997730 hasConceptScore W4295997730C147789679 @default.
• W4295997730 hasConceptScore W4295997730C178790620 @default.
• W4295997730 hasConceptScore W4295997730C181389837 @default.
• W4295997730 hasConceptScore W4295997730C185592680 @default.
• W4295997730 hasConceptScore W4295997730C187530423 @default.
• W4295997730 hasConceptScore W4295997730C192562407 @default.
• W4295997730 hasConceptScore W4295997730C2776042228 @default.
• W4295997730 hasConceptScore W4295997730C2776954882 @default.
• W4295997730 hasConceptScore W4295997730C2777239854 @default.
• W4295997730 hasConceptScore W4295997730C2777419714 @default.
• W4295997730 hasConceptScore W4295997730C2779345167 @default.
• W4295997730 hasConceptScore W4295997730C2779587474 @default.
• W4295997730 hasConceptScore W4295997730C2780035454 @default.
• W4295997730 hasConceptScore W4295997730C2780261241 @default.
• W4295997730 hasConceptScore W4295997730C2994497548 @default.

• next